ArticleGranulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK InhibitorsAuthor:Jordan L. Bormann, MD Publish date: September 21, 2023Granulomatous dermatitis (GD) has been described as a rare side effect of MEK and BRAF inhibitor use in the treatment of BRAF V600E mutation–positi... Read More
